PL3124480T3 - Związek amidowy - Google Patents

Związek amidowy

Info

Publication number
PL3124480T3
PL3124480T3 PL15770149T PL15770149T PL3124480T3 PL 3124480 T3 PL3124480 T3 PL 3124480T3 PL 15770149 T PL15770149 T PL 15770149T PL 15770149 T PL15770149 T PL 15770149T PL 3124480 T3 PL3124480 T3 PL 3124480T3
Authority
PL
Poland
Prior art keywords
amide compound
amide
compound
Prior art date
Application number
PL15770149T
Other languages
English (en)
Inventor
Takao Okuda
Eisuke Nozawa
Tohru UGAWA
Ryo Mizoguchi
Original Assignee
Astellas Pharma Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc. filed Critical Astellas Pharma Inc.
Publication of PL3124480T3 publication Critical patent/PL3124480T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL15770149T 2014-03-26 2015-03-25 Związek amidowy PL3124480T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2014064590 2014-03-26
PCT/JP2015/059026 WO2015147020A1 (ja) 2014-03-26 2015-03-25 アミド化合物
EP15770149.1A EP3124480B1 (en) 2014-03-26 2015-03-25 Amide compound

Publications (1)

Publication Number Publication Date
PL3124480T3 true PL3124480T3 (pl) 2018-10-31

Family

ID=54195532

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15770149T PL3124480T3 (pl) 2014-03-26 2015-03-25 Związek amidowy

Country Status (14)

Country Link
US (1) US10106523B2 (pl)
EP (1) EP3124480B1 (pl)
JP (1) JP6428763B2 (pl)
KR (1) KR20160138098A (pl)
CN (1) CN106132945B (pl)
AR (1) AR099833A1 (pl)
CA (1) CA2943778A1 (pl)
ES (1) ES2684334T3 (pl)
MX (1) MX368098B (pl)
PL (1) PL3124480T3 (pl)
PT (1) PT3124480T (pl)
RU (1) RU2684906C2 (pl)
TW (1) TW201623277A (pl)
WO (1) WO2015147020A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CR20180323A (es) 2015-11-20 2018-08-06 Idorsia Pharmaceuticals Ltd Derivados de indol n-sustituídos como moduladores de los receptores de pge2
EP3824906A1 (en) 2016-12-21 2021-05-26 Amgen Inc. Anti-tnf alpha antibody formulations
PE20191787A1 (es) 2017-05-18 2019-12-24 Idorsia Pharmaceuticals Ltd Derivados de indol n-sustituidos
KR102612140B1 (ko) 2017-05-18 2023-12-08 이도르시아 파마슈티컬스 리미티드 피리미딘 유도체
AR111808A1 (es) 2017-05-18 2019-08-21 Idorsia Pharmaceuticals Ltd Derivados de pirimidina como moduladores del receptor de pge2
EA201992676A1 (ru) 2017-05-18 2020-05-06 Идорсия Фармасьютиклз Лтд Фенильные производные в качестве модуляторов pge2 рецепторов
US11325899B2 (en) 2017-05-18 2022-05-10 Idorsia Pharmaceuticals Ltd Benzofurane and benzothiophene derivatives as PGE2 receptor modulators
JP7816164B2 (ja) 2020-11-13 2026-02-18 小野薬品工業株式会社 Ep4拮抗薬と免疫チェックポイント阻害物質との併用によるがん治療

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2485485A1 (en) * 2002-05-23 2003-12-04 Theratechnologies Inc. Antagonistic peptides of prostaglandin e2 receptor subtype ep4
AU2007283404B2 (en) * 2006-08-11 2013-04-18 Merck Canada Inc. Thiophenecarboxamide derivatives as EP4 receptor ligands
EP2172447A4 (en) 2007-07-03 2011-08-24 Astellas Pharma Inc amide
ES2518919T3 (es) 2008-05-14 2014-11-05 Astellas Pharma Inc. Derivados del ácido 4-(Indol-7-ilcarbonilaminometil)ciclohexanocarboxílico como antagonistas del receptor EP4 útiles para el tratamiento de la insuficiencia renal crónica o la nefropatía diabética
WO2012039972A1 (en) 2010-09-21 2012-03-29 Eisai R&D Management Co., Ltd. Pharmaceutical composition
WO2012103071A2 (en) 2011-01-25 2012-08-02 Eisai R&D Management Co., Ltd. Compounds and compositions

Also Published As

Publication number Publication date
JPWO2015147020A1 (ja) 2017-04-13
CA2943778A1 (en) 2015-10-01
EP3124480B1 (en) 2018-07-11
EP3124480A1 (en) 2017-02-01
TW201623277A (zh) 2016-07-01
CN106132945B (zh) 2019-04-26
US20180030030A1 (en) 2018-02-01
RU2016141650A (ru) 2018-04-27
RU2684906C2 (ru) 2019-04-16
JP6428763B2 (ja) 2018-11-28
PT3124480T (pt) 2018-10-04
EP3124480A4 (en) 2017-11-22
AR099833A1 (es) 2016-08-24
KR20160138098A (ko) 2016-12-02
MX2016012318A (es) 2017-02-23
RU2016141650A3 (pl) 2018-11-12
US10106523B2 (en) 2018-10-23
CN106132945A (zh) 2016-11-16
MX368098B (es) 2019-09-19
WO2015147020A1 (ja) 2015-10-01
ES2684334T3 (es) 2018-10-02

Similar Documents

Publication Publication Date Title
AP2017009836A0 (en) Aminopyridyloxypyrazole compounds
GB201417002D0 (en) Novel compound
GB201411418D0 (en) Compounds
GB201415573D0 (en) Compounds
GB201418300D0 (en) Compounds
GB201410430D0 (en) Compounds
GB201417561D0 (en) Compounds
GB201416186D0 (en) Compounds
GB201402431D0 (en) Compounds
GB201417369D0 (en) Compounds
GB201406591D0 (en) Compounds
GB201406956D0 (en) Compounds
GB201404987D0 (en) Compounds
PT3124480T (pt) Composto de amida
GB201412660D0 (en) Compounds
GB201413695D0 (en) Compound
AP2017009778A0 (en) Azetidinyloxyphenylpyrrolidine compounds
GB201412238D0 (en) Compound
IL248983A0 (en) new compounds
GB201417168D0 (en) Compounds
GB201407694D0 (en) Compound
GB201407506D0 (en) Novel compound
GB201407693D0 (en) Compound
GB201407695D0 (en) Compounds
GB201418709D0 (en) Compound